Surgical Science Sweden

Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.

Tom Englund takes over as the new CEO of Surgical Science

In July, it was announced that Tom Englund will take over as the new CEO of Surgical Science on October 1, 2024. Tom starts his new position as of today and succeeds Gisli Hennermark, who remains in an advisory role until the end of March 2025. Gisli also continues as a member of the Board of Surgical Science. Before his appointment, Tom has bought 2,430 shares in Surgical Science.

Gothenburg, Sweden, October 1, 2024
Surgical Science Sweden AB (publ)

This press release, in its entirety, is available through the attachment or via:
https://surgicalscience.com/investor-relations/#press-releases

See also press release from July 1, 2024, "Tom Englund appointed new CEO of Surgical Science"

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

Datum 2024-10-01, kl 08:30
Källa MFN